News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘MultipleMyeloma’ clear

  • Dana-Farber scientists and colleagues report on a compound that can stop the blood cancer multiple myeloma from spreading, leading to a new approach in addressing metastasis, one of the deadliest aspects of cancer.

Tags: BasicResearch, MultipleMyeloma

  • Researchers at Dana-Farber and Brigham and Women's Hospital (BWH) have utilized nanomedicine technologies to develop a drug-delivery system that can precisely target and attack cancer cells in the bone, as well as increase bone strength and volume to prevent bone cancer progression.

Tags: BasicResearch, MultipleMyeloma

  • The most comprehensive genetic study to date of the blood cancer multiple myeloma has revealed that the genetic landscape of the disease may be more complicated than previously thought.

Tags: BasicResearch, MultipleMyeloma, Genetics

  • Dana-Farber scientists have discovered the mechanism behind thalidomide's cancer-killing properties, which could aid development of safer versions and a new class of cancer drugs.

Tags: BasicResearch, MultipleMyeloma, Lymphoma

  • Ken Anderson, MD, briefed members of Congress and their legislative staffs on blood cancer care and research, and the importance of protecting and enhancing federal research funding.

Tags: Grants, MultipleMyeloma

  • Dana-Farber researchers report that the molecule P5091 triggers cell death in multiple myeloma cancer cells that have become resistant to Velcade.

Tags: BasicResearch, MultipleMyeloma

  • Scientists have created a "cocktail" combination of four antigenic peptides derived from myeloma cells they believe could provoke the body's defenses to attack multiple myeloma in its early "smoldering" phase and slow or prevent the blood cancer.

Tags: BasicResearch, MultipleMyeloma

  • A phase 2 clinical trial has shown that pairing bortezomib with an experimental drug, panobinostat, may be a promising treatment for patients with advanced multiple myeloma when the targeted drug bortezomib stops working alone.

Tags: MultipleMyeloma

  • Dana-Farber researchers successfully disrupted the function of the gene MYC  by tampering with the gene's "on" switch and growth signals in multiple myeloma cells, offering promising strategy for treating myeloma and other cancers driven by the MYC gene.

Tags: BasicResearch, MultipleMyeloma

  • The American Society of Clinical Oncology named Ken Anderson, MD, its 2011 David A. Karnofsky Memorial Award and Lecture honoree for his outstanding achievements in cancer research and patient treatment.

Tags: Honors, MultipleMyeloma

Showing 1-10 of 12 items